Cargando…
Bevacizumab is associated with cerebral microstructural alterations: a DTI study in high-grade glioma
BACKGROUND: For recurrent high-grade glioma, especially glioblastoma, no standard of care treatment exists. Due to the prolongation of progression-free survival and a cortiocosteroid-sparing effect, bevacizumab is often used in this condition. Despite initial clinical responses, there is growing evi...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10247958/ https://www.ncbi.nlm.nih.gov/pubmed/37305747 http://dx.doi.org/10.3389/fneur.2023.1191226 |